LAFP – 77th Annual Assembly and Exhibition Conference

Baytowne Conference Center in Destin, FL

Part 1: Saturday, July 27th, 9:00 AM-10:30 AM

Part 2: Workshop: Saturday, July 27th, 3:30 PM-4:30 PM

Gain expert insights on the weighty impact of obstructive sleep apnea – from underdiagnosis and complex comorbidities, to decreased quality of life and ballooning healthcare cost. Walk away with up to 2.5 AAFP Prescribed credits and actionable strategies you can put to practice to help your patients sleep better and breathe easier.

Get ready for an exciting series featuring two LIVE activities at the LAFP – 77th Annual Assembly and Exhibition in Destin, FL, on July 27, 2024! 

If you can’t make it to Part 1 from 9:00-10:30 AM, don’t worry – we’ve got on-demand options just for you below. But before we dive into Part 2, let’s tailor this experience to your chapter by filling out our quick pre-activity survey.

Can’t join us for Part 1? No problem! Simply click those buttons below to dive into the enduring activities. 

Enduring 1
Enduring 2
Enduring 3
Please enable JavaScript in your browser to complete this form.
Name
Would you like to receive a text message reminder for this Workshop?
1. What percent of adults with OSA go undiagnosed, despite receiving adequate access to health care?
2. What percent of people with OSA are also people with obesity?
3. Betsy is a 48-year-old patient presenting to your clinic for an annual visit. She has a BMI of 36 and a history of hypertension, diabetes, and reports symptoms of insomnia. She also reports that her partner says that she gasps in her sleep. Which additional clinical factors would you assess if using the STOP-Bang questionnaire to gather a sleep history from Betsy
4. A female with hypertension presents to your clinic endorsing symptoms of depression, headache, and fatigue. She does not report any experiences with insomnia symptoms or sleepiness. Based on her report, which of the following phenotypes of OSA might she have?
5. Andre is a male with obesity who comes for his annual physical at your clinic. Through previously diagnosed with OSA, his symptoms have not resolved with CPAP device treatment or with lifestyle modification of diet and exercise. Furthermore, he reports discomfort with CPAP use and would like to avoid devices. Andre is interested in exploring other treatment modalities for OSA. To facilitate shared decision making, which of the following points would you provide around additional treatment options in OSA?
6. Lin, who has overweight, presents at your clinic with complaints of daytime fatigue and loud snoring. Lin has not been diagnosed or treated for OSA, but you identify her as at-risk after evaluation with the STOP-BANG questionnaire. Lin relies on her children for transportation and is underinsured. Lin also expresses anxiety around spending time in clinic settings. Which of the following steps are you likely to recommend to Lin?
7. Miranda is a patient who is using CPAP to manage her moderate OSA (AHI=18). Miranda has found her CPAP device to be uncomfortable due to a feeling of claustrophobia and inability to tolerate the mask, despite trying multiple masks and pressure settings, and despite spending 2 sessions with the PAP therapist in PAP clinic. A change to BiPAP has not helped. Her PAP machine is interrogated and reveals an average use of less than 1 hour per night over the prior month, with a residual AHI of 15. She is dissatisfied with its results. Miranda presents today with BMI of 37 (increase over her past visit of 34). Which of the following factors in Miranda’s case is TRUE?
Click Here to Claim Credit
Scroll to Top